anmelden
Werbung
Anlageziel
The Fund is actively managed and its main objective is to seek to maximise total return. The BlueBox Precision Medicine Fund invests globally with at least 85% of its total assets in the equity securities of companies whose predominant economic activity is in the pharmaceuticals, biotechnology and life science sectors. The remaining 15% of the total assets of the BlueBox Precision Medicine Fund may be invested in equity securities of companies or issuers of any size in any sector of the economy globally and whose predominant economic activity is not in the pharmaceuticals, biotechnology and life science sectors.
Stammdaten
| Name | BlueBox Precision Medicine Fund Class R UK GBP Acc Fonds |
| ISIN | LU2992394382 |
| WKN | |
| Fondsgesellschaft | BlueBox Asset Management UK Ltd |
| Benchmark | N/A |
| Ausschüttungsart | Thesaurierend |
| Manager | Mark Dainty, Polina Suter |
| Domizil | Luxembourg |
| Fondskategorie | Aktien |
| Auflagedatum | 11.03.2025 |
| Geschäftsjahr | 31.12. |
| VL-fähig? | Nein |
| Depotbank | Northern Trust Global Services SE |
| Zahlstelle | |
| Riester Fonds | Nein |
Basisdaten
| Auflagedatum | 11.03.2025 |
| Depotbank | Northern Trust Global Services SE |
| Zahlstelle | |
| Domizil | Luxembourg |
| Geschäftsjahr | 31.12. |
Aktuelle Daten
| Morningstar Rating | |
| Aktueller Rücknahmepreis | 1.432,45 |
| Anzahl Fonds der Kategorie | 845 |
| Volumen der Tranche | 2,39 Mio. GBP |
| Fondsvolumen | 80,66 Mio. GBP |
| Total Expense Ratio (TER) | 1,72 |
Gebühren
| Laufende Kosten | 1,72% |
| Total Expense Ratio (Verwaltungsgebühren & sonst. Kosten) | 1,72% |
| Transaktionskosten | - |
| Depotbankgebühr | - |
| Managementgebühr | 1,00% |
| Rücknahmegebühr | - |
| Ausgabeaufschlag | - |
Performancedaten
| Veränderung Vortag | 25,00 |
| WE seit Jahresbeginn | 6,02% |
